Genetic Immunity, InPlay Completes Patient Enrollment In Phase II Trial Of DermaVir Patch HIV Immunotherapeutic Nanomedicine Lead Product Candidate
June 14, 2009 by admin
Power of the Dream Ventures, Inc. (OTCBB: PWRV), Hungary’s premier technology acquisition and development company, is pleased to present this Genetic Immunity release, based on a previously announced agreement whereby Power of the Dream Ventures will issue communications for Genetic Immunity on a going forward basis.
Comments
Feel free to leave a comment...
and oh, if you want a pic to show with your comment, go get a gravatar!